CRP and neoplasm: Thus, either common markers such as serum CRP or white blood cell subtypes, as well as more sophisticated markers such as MMPs or COX-2, may provide new insights into the molecular mechanisms of tumour development and progression and could open new pathways in diagnosis, prognosis, and therapeutic approach for OSCC.